Virus and antigen conjugation
AssigneeKbio Holdings Limited
InventorsLeigh Burden, Steven D. Hume, Joshua Morton, Greg Pogue, Barry Bratcher, Hugh A. Haydon, Carrie A. Simpson, Nick Partain, John W. Shepherd
Life of this patent
Estimating the term…
Loading patent…
AssigneeKbio Holdings Limited
InventorsLeigh Burden, Steven D. Hume, Joshua Morton, Greg Pogue, Barry Bratcher, Hugh A. Haydon, Carrie A. Simpson, Nick Partain, John W. Shepherd
Estimating the term…
Various embodiments disclosed herein include methods and exemplary compositions associated with conjugation of virus and proteins (e.g., antigen) to form vaccines for delivery of immunological and other therapeutic agents, exemplary aspects of which may include harvesting viral and antigenic substances from source organisms; purifying the viral and protein (e.g. antigenic, including influenza hemagglutinin antigens) substances through methodologies described in an exemplary manner, as well as their concentration and collection; and a conjugation platform providing activation of the virus at a pH that increases binding rate and binding propensity between the virus and the protein, wherein embodiments related to the conjugation platform include controlling the ratio of virus to protein.
A composition comprising a virus-antigen conjugate, wherein the antigen conjugated to the virus comprises an influenza hemagglutinin antigen (HA) and exhibits at least about 50% trimer formation.
A composition comprising a virus-antigen conjugate wherein the antigen conjugated to the virus comprises an influenza hemagglutinin antigen (HA) and exhibits at least about 50% trimer formation, wherein the HA component is multivalent and comprises two or more HAs conjugated to the virus.
Dependencies are inferred from the claim text.